跳至主要内容
临床试验/CTRI/2024/05/067698
CTRI/2024/05/067698尚未招募2 期

Single centric Non- Randomised open clinical trial Phase ll in Uratha Pitha Vatham (Essential Hypertension) with the Siddha medicine Athimathura chooranam among patients attending OPD at Government Siddha Medical College Hospital Chennai Chennai.,

N RAKSHANA1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年9月9日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
The outcome of this treatment will be as follows.The blood pressure reduction of 80% is taken as good,reduction in 50% is taken as moderate,20% reduction is taken as poor.

研究概览

简要总结

Hypertension or high blood pressure is a chronic condition in which blood pressure in arteries is higher than the normal. This condition can put extra strain on the heart and circulatory system , which must work harder to circulate the blood. Hypertension is a major risk factor for variety of cardiovascular diseases , including coronary artery disease , heart failure ,stroke and peripheral vascular disease.

The aim of the study is the clinical management of Uratha Pitha Vatham (ESSENTIAL HYPERTENSION) with the siddha trial Medicine Athimathura Chooranam. Thus in Siddha system of Medicine , there are unique combination of medicines which have the solution to Hypertension. One such combination is Athimathura Chooranam which is mentioned in Pathartha Guna Vilakam. The hypothesis is created in such a way  to evaluate the efficacy of Athimathura Chooranam in the management of Hypertension.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 59.00 Year(s)(—)
性别
All

入选标准

  •  Grade 1 SBP ≥140 mmHg and 159 mmHg DBP ≥90 mmHg and 99 mmHg  Grade 2 SBP ≥160 mmHg and 179mmHg DBP≥100 mmHg and 109mmHg.

排除标准

  •  Age above 60 yrs  Vulnerable Population.
  •  Associated Serious Illness.
  •  Grade III SBP ≥180 mmHg DBP ≥110 mmHg.

结局指标

主要结局

The outcome of this treatment will be as follows.The blood pressure reduction of 80% is taken as good,reduction in 50% is taken as moderate,20% reduction is taken as poor.

时间窗: 3 Months

次要结局

  • Reduction in Total Cholesterol levels(3 Months)

研究者

发起方
N RAKSHANA
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr N Rakshana

Government Siddha Medical College,Arumbakkam

研究点 (1)

Loading locations...

相似试验